<DOC>
	<DOCNO>NCT01454115</DOCNO>
	<brief_summary>The primary objective ass safety tolerability single oral dose BMS-708163 healthy young male subject elderly male female subject .</brief_summary>
	<brief_title>Study Evaluate Safety , Pharmacokinetics Tolerability BMS-708163</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Panels 1 8 Panels 1415 : healthy male subject age 18 45 Panels 9 10 : healthy elderly male female age 60 great Panel 11 : healthy male age 4659 Panel 12 : male and/or female either healthy mild cognitive impairment ( MCI ) age 60 74 Panel 13 : male and/or female , healthy Alzheimer 's disease ( AD ) MCI 75 year age great Acceptable medical history , physical examination , vital sign , electrocardiogram , hemoccult stool test , clinical laboratory evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>